Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

about

Older men display elevated levels of senescence-associated exercise-responsive CD28null angiogenic T cells compared with younger men.

P2860

Q55340122-199A3A9E-AFC4-4360-BFE7-FCE1CEDB631C

P2860

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

Item

http://www.wikidata.org/entity/Q40090125

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

@en

type

Item

label

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

@en

prefLabel

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

@en

P1476

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

@en

P2093

Andreas P Kalogeropoulos

http://www.w3.org/2001/XMLSchema#string

Arshed A Quyyumi

http://www.w3.org/2001/XMLSchema#string

Ayman Alkhoder

http://www.w3.org/2001/XMLSchema#string

Ayman Samman Tahhan

http://www.w3.org/2001/XMLSchema#string

Edmund K Waller

http://www.w3.org/2001/XMLSchema#string

Ernestine Mahar

http://www.w3.org/2001/XMLSchema#string

Heval Mohamed Kelli

http://www.w3.org/2001/XMLSchema#string

Hiroshi Aida

http://www.w3.org/2001/XMLSchema#string

Iraj Hesaroieh

http://www.w3.org/2001/XMLSchema#string

Jonathan H Kim

http://www.w3.org/2001/XMLSchema#string

P2860

AC133, a novel marker for human hematopoietic stem and progenitor cells

CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.

Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Circulating stem cell vary with NYHA stage in heart failure patients.

Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.

Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.117.004106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salim Hayek

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28790053

http://www.w3.org/2001/XMLSchema#string

P932

5809135

http://www.w3.org/2001/XMLSchema#string

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

about

P2860

P2860

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932